327 related articles for article (PubMed ID: 20594944)
1. New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Ghelardini C; Mura P
Int J Pharm; 2010 Aug; 395(1-2):222-31. PubMed ID: 20594944
[TBL] [Abstract][Full Text] [Related]
2. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
3. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes.
Mura P; Maestrelli F; González-Rodríguez ML; Michelacci I; Ghelardini C; Rabasco AM
Eur J Pharm Biopharm; 2007 Aug; 67(1):86-95. PubMed ID: 17350813
[TBL] [Abstract][Full Text] [Related]
4. Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anesthetic efficacy.
Bragagni M; Maestrelli F; Mennini N; Ghelardini C; Mura P
J Liposome Res; 2010 Dec; 20(4):315-22. PubMed ID: 20109055
[TBL] [Abstract][Full Text] [Related]
5. Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes.
Maestrelli F; Capasso G; González-Rodríguez ML; Rabasco AM; Ghelardini C; Mura P
J Liposome Res; 2009; 19(4):253-60. PubMed ID: 19863160
[TBL] [Abstract][Full Text] [Related]
6. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
Tewes F; Brillault J; Couet W; Olivier JC
J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
[TBL] [Abstract][Full Text] [Related]
7. Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics.
Piel G; Piette M; Barillaro V; Castagne D; Evrard B; Delattre L
Int J Pharm; 2006 Apr; 312(1-2):75-82. PubMed ID: 16455215
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes--comparison with conventional methods.
Al-Marzouqi AH; Jobe B; Dowaidar A; Maestrelli F; Mura P
J Pharm Biomed Anal; 2007 Jan; 43(2):566-74. PubMed ID: 17010552
[TBL] [Abstract][Full Text] [Related]
10. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
11. Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome.
Gillet A; Grammenos A; Compère P; Evrard B; Piel G
Int J Pharm; 2009 Oct; 380(1-2):174-80. PubMed ID: 19576972
[TBL] [Abstract][Full Text] [Related]
12. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
13. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
15. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
16. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
[TBL] [Abstract][Full Text] [Related]
17. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
19. Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin.
Mura P; Bragagni M; Mennini N; Cirri M; Maestrelli F
Int J Pharm; 2014 Nov; 475(1-2):306-14. PubMed ID: 25194352
[TBL] [Abstract][Full Text] [Related]
20. Optimization of formulation variables of benzocaine liposomes using experimental design.
Mura P; Capasso G; Maestrelli F; Furlanetto S
J Liposome Res; 2008; 18(2):113-25. PubMed ID: 18569447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
